In summary, our research has revealed a novel mechanism in which gankyrin increases the expression of SLC7A11 and GPX4 through p53 ubiquitination, thus hindering ferroptosis-induced cell death in TNBC and potentially facilitating cancer cell survival. Here, TP53 is linked to cancer.